GOLIMUMAB - A NEW TNF α-BLOCKER. THE REVIEW OF THE EFFICACY AND SAFETY EVALUATION RESULTS

The article represents the results of efficacy and safety evaluation of the human monoclonal antibodies - golimumab, according to the data of international multicenter randomized double-blind placebo-controlled trials, including patients with active stage of rheumatoid arthritis. It was shown, that...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: R. V. Denisova (Autor), E. I. Alexeeva (Autor)
Format: Knjiga
Izdano: "Paediatrician" Publishers LLC, 2012-07-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno